Heterocyclic quinones with potential antitumor activity. 2. Synthesis and antitumor activity of some benzimidazole-4,7-dione derivatives. 1988

I Antonini, and F Claudi, and G Cristalli, and P Franchetti, and M Grifantini, and S Martelli
Dipartimento di Scienze Chimiche, Universitá di Camerino, Italy.

A series of benzimidazole-4,7-dione derivatives, bearing substituents at positions 1, 2, 5, and 6 of the benzimidazole ring, has been synthesized and tested for antitumor activity in vivo on P388 leukemia. Some of the synthesized compounds show significant antitumor activity, associated with high toxicity, however. Compounds 7, 18, and 27 show the highest antitumor activity in this series, whereas 17, 19, and 22 are scarcely active. Some hypothetical biological precursors of these quinones are devoid of antitumor activity. Some structure-activity relationships are discussed.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007941 Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. P388D(1) Leukemia,P388, Leukemia
D011809 Quinones Hydrocarbon rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

I Antonini, and F Claudi, and G Cristalli, and P Franchetti, and M Grifantini, and S Martelli
October 2000, Bioorganic & medicinal chemistry letters,
I Antonini, and F Claudi, and G Cristalli, and P Franchetti, and M Grifantini, and S Martelli
August 2000, Archives of pharmacal research,
I Antonini, and F Claudi, and G Cristalli, and P Franchetti, and M Grifantini, and S Martelli
September 2014, Molecules (Basel, Switzerland),
I Antonini, and F Claudi, and G Cristalli, and P Franchetti, and M Grifantini, and S Martelli
December 2013, Molecules (Basel, Switzerland),
I Antonini, and F Claudi, and G Cristalli, and P Franchetti, and M Grifantini, and S Martelli
October 1977, Die Pharmazie,
I Antonini, and F Claudi, and G Cristalli, and P Franchetti, and M Grifantini, and S Martelli
August 1978, Die Pharmazie,
I Antonini, and F Claudi, and G Cristalli, and P Franchetti, and M Grifantini, and S Martelli
July 2010, European journal of medicinal chemistry,
I Antonini, and F Claudi, and G Cristalli, and P Franchetti, and M Grifantini, and S Martelli
December 1986, Il Farmaco; edizione scientifica,
I Antonini, and F Claudi, and G Cristalli, and P Franchetti, and M Grifantini, and S Martelli
March 1966, Journal of medicinal chemistry,
I Antonini, and F Claudi, and G Cristalli, and P Franchetti, and M Grifantini, and S Martelli
September 1982, Il Farmaco; edizione scientifica,
Copied contents to your clipboard!